NETTER-1 and Octreotide for Advanced Small Bowel Carcinoids

NETTER-1 and Octreotide for Advanced Small Bowel Carcinoids

User Photo
NCCN2017

3 years
2,377 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School discusses the results of the NETTER-1 study, which concluded with patients who were treated with octreotide had significantly improved progression free survival compared to patients who were not treated with the drug. This was recorded at the 2017 National Comprehensive Cancer Network (NCCN) Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care in Orlando, Florida.
Up Next Autoplay
User Photo